Analyst Reaffirms Buy Rating and 120 Price Target for Viking Therapeutics
Maxim Group analyst Naz Rahman has once again expressed optimism in Viking Therapeutics (NASDAQ: VKTX), reiterating a Buy rating and ...
Tag: VKTX
Analyzing Viking Therapeutics Stock Performance and Buyback Initiatives
Viking Therapeutics (VKTX) stock has been on a rollercoaster ride, dropping by 10.9% on a recent Monday afternoon. This dip ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
